Literature DB >> 1007165

Specificity and possible origin of anti-N antibodies developed by patients undergoing chronic haemodialysis.

B Boettcher, R S Nanra, T K Roberts, M Mallan, C A Watterson.   

Abstract

Studies were performed on two anti-N sera from patients who had formed anti-N antibodies during their period of haemodialysis. No specific inhibition of these antibodies was obtained by extracts prepared from a new and a used dialysis unit, and it was concluded that there was no evidence of a compound in the units which would stimulate production of the anti-N. The specificity of the anti-N's was shown to be against a precursor of MN antigens, since all activity in the sera could be removed by neuraminidase-treated M cells, which expressed MN precursor. Since the anti-N's would react with untreated N cells only at 4 degrees C, but with formaldehyde-treated cells at 4, 25 and 37 degrees C, it was concluded that the specificity of the anti-N's was directed against an antigen developed by red cells after formaldehyde treatment. It is proposed that the production of the anti-N antibodies is stimulated by formaldehyde-treated red cells passing into the patient during re-use of a dialysis unit sterilized with formaldehyde.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1007165     DOI: 10.1111/j.1423-0410.1976.tb04455.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  3 in total

1.  Relationship between formaldehyde-related antibodies and cross-reacting anti-N-like antibodies in patients undergoing chronic haemodialysis.

Authors:  R Sharon
Journal:  J Clin Pathol       Date:  1981-01       Impact factor: 3.411

2.  Formaldehyde induced anti-N: a possible cause of renal graft failure.

Authors:  D W Gorst; R A Riches; P H Renton
Journal:  J Clin Pathol       Date:  1977-10       Impact factor: 3.411

3.  Report on the Consensus Workshop on Formaldehyde.

Authors: 
Journal:  Environ Health Perspect       Date:  1984-12       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.